PinnedReynold Lemkins Group·Aug 10, 2025Post-Figma: Asia’s Design-to-Dev MomentWhy this IPO matters for product velocity and APAC go-to-market
Reynold Lemkins Group·Nov 26, 2025Why We Are Betting on the Convergence of Heritage Real Estate and RWAWe recently announced a strategic investment in ITC Properties (00199.HK), acquiring a 10% stake with a voluntary 12-month lock-up period.
Reynold Lemkins Group·Aug 23, 2025When the Fed Blinks, Cross-Border Windows ReopenWhat a 2025 easing cycle could mean for US↔APAC capital, and how to position now
Reynold Lemkins Group·Aug 16, 2025Space IPOs Are Back: Why Asia is the “Quiet Alpha” Behind the U.S. LaunchesFirefly’s strong debut is a reminder: when the spotlight is on launches, the real story is often happening behind the scenes in the global…
Reynold Lemkins Group·Aug 4, 2025Bridging Capital to the Future of Health: Why We Backed Cloudbreak Pharma’s HKEX IPOAt Reynold Lemkins Group, our mission goes beyond capital deployment — it’s about empowering the companies that are actively redefining…
Reynold Lemkins Group·Jun 20, 2025From Hong Kong to New York: Reynold Lemkins Group’s Cross-Border Capital VisionIn the heart of this year’s NY Tech Week, one message echoed louder than most: capital knows no borders. For Reynold Lemkins Group, this…
Reynold Lemkins Group·Jun 8, 2025Bridging Capital and Strategy: Reynold Lemkins at the Greenwich Economic Forum Hong Kong 2025As global capital flows recalibrate in a new era of geopolitical flux and technological acceleration, Reynold Lemkins was honored to…
Reynold Lemkins Group·May 5, 2025Venture Capital’s Next Act: How Top Firms Are Shifting Toward a PE-Style FutureIn the past two years, we’ve witnessed a fundamental shift in how top venture capital firms operate. Traditional VC models, invest early…
Reynold Lemkins Group·Apr 21, 2025From Frontier to Foundation: The Shifting Constants in Tech InvestingAs global capital continues to chase the next defining chapter of technology, one thing is clear: we are no longer just investing in…
Reynold Lemkins Group·Apr 3, 2025Reynold Lemkins Backs Visen Pharmaceuticals IPO, Strengthening Cross-Border Investment in AI-Driven…Official Announcement of Investment Participation
